Health Canada drug identification number

DIN 01916823 — RIDAURA 3 MG

RIDAURA is a capsule of Auranofin marketed by XEDITON PHARMACEUTICALS INC. The full Auranofin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
01916823
Brand name
RIDAURA
Active ingredient
Auranofin
Strength
3 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
XEDITON PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Gold compound (antirheumatic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.